Spectral Medical (EDT) Competitors

Spectral Medical (TSE:EDT) and Sernova (TSE:SVA) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, risk, earnings, institutional ownership, media sentiment, profitability, community ranking, dividends and analyst recommendations.

Which has more volatility & risk, EDT or SVA?

Spectral Medical has a beta of 0.91, meaning that its stock price is 9% less volatile than the S&P 500. Comparatively, Sernova has a beta of 1.48, meaning that its stock price is 48% more volatile than the S&P 500.

Which has better earnings & valuation, EDT or SVA?

Spectral Medical has higher revenue and earnings than Sernova. Spectral Medical is trading at a lower price-to-earnings ratio than Sernova, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Spectral Medical	C$1.60M	86.19	-C$15.51M	-C$0.06	-8.25
Sernova	N/A	N/A	-C$40.73M	-C$0.13	-2.85

Does the media prefer EDT or SVA?

In the previous week, Spectral Medical had 1 more articles in the media than Sernova. MarketBeat recorded 2 mentions for Spectral Medical and 1 mentions for Sernova. Spectral Medical's average media sentiment score of -0.42 beat Sernova's score of -0.92 indicating that Spectral Medical is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Spectral Medical	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
Sernova	0 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Negative

Do analysts recommend EDT or SVA?

Sernova has a consensus price target of C$1.50, indicating a potential upside of 305.41%. Given Sernova's higher probable upside, analysts plainly believe Sernova is more favorable than Spectral Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Spectral Medical	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	N/A
Sernova	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

Is EDT or SVA more profitable?

Sernova's return on equity of -183.58% beat Spectral Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Spectral Medical	N/A	-973.97%	-78.75%
Sernova	N/A	-183.58%	-79.96%

Does the MarketBeat Community prefer EDT or SVA?

Spectral Medical received 123 more outperform votes than Sernova when rated by MarketBeat users. However, 88.89% of users gave Sernova an outperform vote while only 65.17% of users gave Spectral Medical an outperform vote.

Company	Underperform	Outperform
Spectral Medical	Outperform Votes 131 65.17%	Underperform Votes 70 34.83%
Sernova	Outperform Votes 8 88.89%	Underperform Votes 1 11.11%

Do institutionals and insiders believe in EDT or SVA?

13.2% of Spectral Medical shares are held by institutional investors. Comparatively, 0.1% of Sernova shares are held by institutional investors. 20.5% of Spectral Medical shares are held by company insiders. Comparatively, 12.7% of Sernova shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Summary

Spectral Medical beats Sernova on 9 of the 14 factors compared between the two stocks.